G.J.M. Maestroni

2.5k total citations · 1 hit paper
24 papers, 1.9k citations indexed

About

G.J.M. Maestroni is a scholar working on Endocrine and Autonomic Systems, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, G.J.M. Maestroni has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrine and Autonomic Systems, 4 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in G.J.M. Maestroni's work include Circadian rhythm and melatonin (18 papers), Tryptophan and brain disorders (4 papers) and Stress Responses and Cortisol (3 papers). G.J.M. Maestroni is often cited by papers focused on Circadian rhythm and melatonin (18 papers), Tryptophan and brain disorders (4 papers) and Stress Responses and Cortisol (3 papers). G.J.M. Maestroni collaborates with scholars based in Switzerland, Italy and Malaysia. G.J.M. Maestroni's co-authors include A. Conti, Walter Pierpaoli, V. Srinivasan, Rüdiger Hardeland, Burkhard Pöeggeler, Daniel P. Cardinali, Seithikurippu R. Pandi‐Perumal, Paolo Lissoni, Gabriele Tancini and Sandro Barni and has published in prestigious journals such as British Journal of Cancer, European Journal of Cancer and FEBS Journal.

In The Last Decade

G.J.M. Maestroni

24 papers receiving 1.8k citations

Hit Papers

Melatonin 2006 2026 2012 2019 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.J.M. Maestroni Switzerland 19 1.3k 432 270 227 216 24 1.9k
Ario Conti Switzerland 22 1.4k 1.0× 492 1.1× 284 1.1× 173 0.8× 111 0.5× 34 1.9k
V. Srinivasan United States 16 1.0k 0.8× 336 0.8× 244 0.9× 317 1.4× 285 1.3× 38 1.8k
M.P. Terrón Spain 17 1.9k 1.4× 569 1.3× 553 2.0× 195 0.9× 129 0.6× 21 3.0k
Luis J. Flores United States 9 1.7k 1.3× 447 1.0× 492 1.8× 169 0.7× 111 0.5× 10 2.6k
M. D. Mediavilla Spain 26 1.6k 1.2× 461 1.1× 509 1.9× 149 0.7× 199 0.9× 43 2.3k
Shiu Fun Pang Hong Kong 25 1.5k 1.1× 381 0.9× 265 1.0× 297 1.3× 106 0.5× 55 1.9k
Erika Cecon France 25 1.6k 1.2× 425 1.0× 608 2.3× 277 1.2× 136 0.6× 48 2.2k
Carmen Osuna Spain 27 1.6k 1.2× 646 1.5× 622 2.3× 144 0.6× 75 0.3× 76 2.9k
Venkatramanujam Srinivasan Canada 11 922 0.7× 297 0.7× 179 0.7× 305 1.3× 268 1.2× 14 1.4k
María Dolores Maldonado y Aibar Spain 18 1.0k 0.8× 342 0.8× 323 1.2× 96 0.4× 70 0.3× 34 1.8k

Countries citing papers authored by G.J.M. Maestroni

Since Specialization
Citations

This map shows the geographic impact of G.J.M. Maestroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.J.M. Maestroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.J.M. Maestroni more than expected).

Fields of papers citing papers by G.J.M. Maestroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.J.M. Maestroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.J.M. Maestroni. The network helps show where G.J.M. Maestroni may publish in the future.

Co-authorship network of co-authors of G.J.M. Maestroni

This figure shows the co-authorship network connecting the top 25 collaborators of G.J.M. Maestroni. A scholar is included among the top collaborators of G.J.M. Maestroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.J.M. Maestroni. G.J.M. Maestroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pandi‐Perumal, Seithikurippu R., V. Srinivasan, G.J.M. Maestroni, et al.. (2006). Melatonin. FEBS Journal. 273(13). 2813–2838. 691 indexed citations breakdown →
2.
Viganò, Daniela, Paolo Lissoni, Franco Rovelli, et al.. (2001). A study of light/dark rhythm of melatonin in relation to cortisol and prolactin secretion in schizophrenia.. PubMed. 22(2). 137–41. 42 indexed citations
3.
Ghielmini, Michele, Olivia Pagani, J. de Jong, et al.. (1999). Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer. British Journal of Cancer. 80(7). 1058–1061. 30 indexed citations
4.
Maestroni, G.J.M.. (1998). Is hematopoiesis under the influence of neural and neuroendocrine mechanisms?. PubMed. 13(1). 271–4. 25 indexed citations
5.
Bubenik, George A., David E. Blask, G.M. Brown, et al.. (1998). Prospects of the Clinical Utilization of Melatonin. Neurosignals. 7(4). 195–219. 117 indexed citations
8.
Ben‐Nathan, D., G.J.M. Maestroni, S. Lustig, & A. Conti. (1995). Protective effects of melatonin in mice infected with encephalitis viruses. Archives of Virology. 140(2). 223–230. 112 indexed citations
9.
Lissoni, Paolo, Sandro Barni, Gabriele Tancini, et al.. (1994). A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma. British Journal of Cancer. 69(1). 196–199. 79 indexed citations
10.
Maestroni, G.J.M., Valeria Covacci, & A. Conti. (1994). Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice.. PubMed. 54(9). 2429–32. 94 indexed citations
11.
Lissoni, Paolo, Sandro Barni, Franco Rovelli, et al.. (1993). Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: Preliminary results. European Journal of Cancer. 29(2). 185–189. 34 indexed citations
12.
Lissoni, Paolo, Sandro Barni, Gabriele Tancini, et al.. (1993). A Study of the Mechanisms Involved in the Immunostimulatory Action of the Pineal Hormone in Cancer Patients. Oncology. 50(6). 399–402. 54 indexed citations
13.
Lissoni, Paolo, Sandro Barni, Antonio Ardizzoia, et al.. (1993). Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients.. PubMed. 6(4). 132–6. 30 indexed citations
14.
Lissoni, P., Antonio Ardizzoia, E. Tisi, et al.. (1993). Amplification of eosinophilia by melatonin during the immunotherapy of cancer with interleukin-2.. PubMed. 7(1). 34–6. 11 indexed citations
15.
Lissoni, Paolo, E. Tisi, F Brivio, et al.. (1992). Modulation of interleukin-2-induced macrophage activation in cancer patients by the pineal hormone melatonin.. PubMed. 5(4). 154–6. 22 indexed citations
16.
17.
Pierpaoli, Walter & G.J.M. Maestroni. (1987). Melatonin: a principal neuroimmunoregulatory and anti-stress hormone: its anti-aging effects. Immunology Letters. 16(3-4). 355–361. 126 indexed citations
18.
Maestroni, G.J.M., A. Conti, & Walter Pierpaoli. (1987). Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism.. PubMed. 68(2). 384–91. 173 indexed citations
19.
Losa, Gabriele A. & G.J.M. Maestroni. (1984). [Clinical and immunobiological action of an orally administered bacterial extract].. PubMed. 114(25). 930–2. 4 indexed citations
20.
Pierpaoli, Walter & G.J.M. Maestroni. (1978). Pharmacological control of the hormonally modulated immune response. II. Blockade of antibody production by a combination of drugs acting on neuroendocrine functions. Its prevention by gonadotropins and corticotrophin.. PubMed. 34(3). 419–30. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026